| Primary |
| Convulsion |
32.7% |
| Epilepsy |
19.3% |
| Product Used For Unknown Indication |
11.2% |
| Accidental Exposure |
6.3% |
| Complex Partial Seizures |
4.9% |
| Multiple Sclerosis |
3.1% |
| Diabetes Mellitus |
2.7% |
| Drug Use For Unknown Indication |
2.7% |
| Denture Wearer |
2.2% |
| Neuralgia |
2.2% |
| Trigeminal Neuralgia |
2.2% |
| Attention Deficit/hyperactivity Disorder |
1.3% |
| Bipolar Disorder |
1.3% |
| Blood Cholesterol Increased |
1.3% |
| Loss Of Control Of Legs |
1.3% |
| Partial Seizures |
1.3% |
| Fatigue |
0.9% |
| Grand Mal Convulsion |
0.9% |
| Pain |
0.9% |
| Premedication |
0.9% |
|
| Convulsion |
16.0% |
| Drug Interaction |
7.4% |
| Treatment Noncompliance |
7.4% |
| Product Quality Issue |
6.2% |
| Vomiting |
6.2% |
| Weight Decreased |
6.2% |
| Death |
4.9% |
| Pharmaceutical Product Complaint |
4.9% |
| Stevens-johnson Syndrome |
4.9% |
| Drug Ineffective |
3.7% |
| Medication Error |
3.7% |
| Somnolence |
3.7% |
| Suicide Attempt |
3.7% |
| Tooth Loss |
3.7% |
| Toxicity To Various Agents |
3.7% |
| Vision Blurred |
3.7% |
| Brain Neoplasm |
2.5% |
| Cataract |
2.5% |
| Drug Level Below Therapeutic |
2.5% |
| Grand Mal Convulsion |
2.5% |
|
| Secondary |
| Convulsion |
20.8% |
| Drug Use For Unknown Indication |
13.4% |
| Epilepsy |
10.0% |
| Product Used For Unknown Indication |
10.0% |
| Neuralgia |
6.1% |
| Foetal Exposure During Pregnancy |
5.6% |
| Multiple Sclerosis |
5.6% |
| Depression |
5.2% |
| Trigeminal Neuralgia |
4.3% |
| Bipolar Disorder |
3.5% |
| Attention Deficit/hyperactivity Disorder |
2.6% |
| Fatigue |
2.2% |
| Complex Partial Seizures |
1.7% |
| Bipolar I Disorder |
1.3% |
| Hydrocephalus |
1.3% |
| Loss Of Control Of Legs |
1.3% |
| Mood Swings |
1.3% |
| Multiple Sclerosis Relapse |
1.3% |
| Non-small Cell Lung Cancer |
1.3% |
| Pain |
1.3% |
|
| Cataract |
10.3% |
| Lethargy |
6.9% |
| Oropharyngeal Pain |
6.9% |
| Suicide Attempt |
6.9% |
| Swelling |
6.9% |
| Vomiting |
6.9% |
| Diabetes Mellitus |
5.2% |
| Medication Error |
5.2% |
| Palpitations |
5.2% |
| Unresponsive To Stimuli |
5.2% |
| Acute Respiratory Distress Syndrome |
3.4% |
| Amnesia |
3.4% |
| Convulsion |
3.4% |
| Dermatitis Allergic |
3.4% |
| Placental Disorder |
3.4% |
| Rash |
3.4% |
| Sinus Tachycardia |
3.4% |
| Skin Haemorrhage |
3.4% |
| Somnolence |
3.4% |
| Speech Disorder |
3.4% |
|
| Concomitant |
| Convulsion |
15.0% |
| Product Used For Unknown Indication |
11.2% |
| Bipolar Disorder |
10.4% |
| Multiple Sclerosis |
8.6% |
| Sleep Disorder |
8.4% |
| Epilepsy |
7.0% |
| Drug Use For Unknown Indication |
6.6% |
| Depression |
6.0% |
| Nuclear Magnetic Resonance Imaging |
4.3% |
| Hypertension |
4.2% |
| Anxiety |
3.4% |
| Chemotherapy |
2.1% |
| Pain |
2.0% |
| Asthma |
1.9% |
| Blood Cholesterol Increased |
1.8% |
| Glioblastoma Multiforme |
1.6% |
| Osteoporosis |
1.6% |
| Neuralgia |
1.4% |
| Grand Mal Convulsion |
1.2% |
| Astrocytoma |
1.2% |
|
| Weight Increased |
37.6% |
| Convulsion |
8.4% |
| Type 2 Diabetes Mellitus |
5.1% |
| Vomiting |
4.6% |
| Somnolence |
4.2% |
| Vision Blurred |
4.2% |
| Weight Decreased |
4.2% |
| Dizziness |
3.4% |
| Drug Ineffective |
3.0% |
| Myocardial Infarction |
3.0% |
| Pain In Extremity |
3.0% |
| Nephrogenic Systemic Fibrosis |
2.5% |
| Memory Impairment |
2.1% |
| Pain |
2.1% |
| Pneumonia |
2.1% |
| Pulmonary Embolism |
2.1% |
| Road Traffic Accident |
2.1% |
| Tremor |
2.1% |
| Urticaria |
2.1% |
| White Blood Cell Count Decreased |
2.1% |
|
| Interacting |
| Convulsion |
50.0% |
| Smoking Cessation Therapy |
25.0% |
| Tuberous Sclerosis |
25.0% |
|
| Drug Interaction |
66.7% |
| Pyrexia |
33.3% |
|
